EMEA-001005-PIP01-10-M01
Key facts
Invented name |
Kaletra
|
Active substance |
|
Therapeutic area |
Infectious diseases
|
Decision number |
P/0144/2012
|
PIP number |
EMEA-001005-PIP01-10-M01
|
Pharmaceutical form(s) |
|
Condition(s) / indication(s) |
Treatment of human immunodeficiency virus (HIV-1) infection
|
Route(s) of administration |
Oral use
|
Contact for public enquiries |
AbbVie Ltd
|
Decision type |
PM: decision on the application for modification of an agreed PIP
|
Compliance procedure number |
EMEA-C-001005-PIP01-10-M01
|
Compliance opinion date |
17/07/2015
|
Compliance outcome |
positive
|